Metagenics

Metagenics Andrographis Plus 30 Tablets

Metagenics

Metagenics Andrographis Plus 30 Tablets

Barcode: 755571011152
Size: 30
Form: Tablet

Andrographis Plus 30 Tablet

Andrographis Plus delivers a proprietary blend of Ayurvedic and Asian herbs including concentrated andrographis extract and amla designed to support immune health. A proprietary herbal preparation traditionally used to support lung health rounds out this advanced immune support formula.

  • non-GMO
  • gluten free
  • vegetarian

Suggested Use As a dietary supplement Take as directed by your healthcare practitioner. - Or as directed by your healthcare professional.


Supplement Facts


Serving Size 1 Tablet Servings Per Container 30


Amount Per Serving% Daily Value***


Andrographis Andrographis paniculata Andrographis Andrographis paniculata 200 mg *


Amla Emblica officinalis Fruit 51 Extract containing tannins 200 mg *


A 51 Proprietary Herbal Extract Blend of 200 mg *


Glehnia Glehnia littoralis Root, Apricot Prunus armeniaca Seed, White Mulberry Morus alba Leaf, Gardenia Gardenia jasminoides Fruit, Soybean Glycine max , Zhejiang Fritillary Fritillaria thunbergii Bulb, Pear Pyrus pyrifolia Fruit


***Percent Daily Values are based on a 2,000 calorie diet

Other IngredientsMicrocrystalline cellulose, andrographis leaf extract, amla fruit extract, glehnia root extract, apricot seed extract, white mulberry leaf extract, gardenia fruit extract, soybean soy , zhejiang fritillary bulb extract, pear fruit extract, cellulose, croscarmellose sodium, calcium silicate, stearic acid vegetable , silica, magnesium stearate vegetable , and coating hypromellose, medium chain triglycerides, and hydroxypropylcellulose . Contains Soy.


WarningsKeep out of reach of children. As with all dietary supplements, consult your healthcare professional before use. See product label for more information. Do not use if pregnant or nursing. Caution Consult your healthcare practitioner before use. If taking heart medications or have a chronic health condition, please inform your healthcare practitioner.


Subscribe